The Spanish Competition Authority closes abuse of dominance proceedings by means of a commitments decision against a pharmaceutical company (IMS Health)

On 13 July 2017, the NMCC closed the Article 102 TFEU and Article 2 of the Spanish Competition Act (Competition Act) proceedings related to the supply of pharmaceutical marketing data to IMS Health (IMS) by means of a commitments decision. The NMCC initiated the investigation, as a result of the complaint lodged by Health market Research España (HmR) against IMS for abuse of dominant position by establishing a network of data supply agreements

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • Callol, Coca & Asociados (Madrid)

Quotation

Pedro Callol, The Spanish Competition Authority closes abuse of dominance proceedings by means of a commitments decision against a pharmaceutical company (IMS Health), 13 July 2017, e-Competitions Bulletin November 2017, Art. N° 85250

Visites 78

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues